Aneurysmal fibrous histiocytomas with recurrent rearrangement of the PRKCD gene and LAMTOR1-PRKCD fusions

2018 ◽  
Vol 45 (12) ◽  
pp. 966-968 ◽  
Author(s):  
Jaroslaw J. Jedrych ◽  
Sekhar Duraisamy ◽  
Arivarasan Karunamurthy
1989 ◽  
Vol 18 (2) ◽  
pp. 171-179 ◽  
Author(s):  
Robert J. Fieldman ◽  
Todd A. Morrow

1984 ◽  
Vol 108 (3) ◽  
pp. 364-365 ◽  
Author(s):  
Akihiko Maekawa ◽  
Toshiaki Ogiu ◽  
Hiroshi Onodera ◽  
Kyoko Furuta ◽  
Chiaki Matsuoka ◽  
...  

2004 ◽  
Vol 40 (1) ◽  
pp. 32-37 ◽  
Author(s):  
Frédéric Chibon ◽  
Odette Mariani ◽  
Josette Derré ◽  
Aline Mairal ◽  
Jean-Michel Coindre ◽  
...  

2020 ◽  
Vol 30 (8) ◽  
pp. 1118-1123
Author(s):  
Sarah Johnson ◽  
Malte Renz ◽  
Lindsay Wheeler ◽  
Elisabeth Diver ◽  
Oliver Dorigo ◽  
...  

ObjectiveVulvar cancers account for 5% of all gynecologic malignancies; only 1%–3% of those vulvar cancers are primary vulvar sarcomas. Given the rarity of vulvar sarcomas, outcome data specific to histopathologic subtypes are sparse. The aim of this study was to identify clinical and pathologic factors of primary vulvar sarcomas that are associated with survival and may inform treatment decisions.MethodsThe Surveillance, Epidemiology, and End Results (SEER) database was searched for women diagnosed with vulvar sarcoma between 1973 and 2018. We identified 315 patients and reviewed their demographic, clinicopathologic, surgical, and survival information. Statistical analyses included χ2 and t-tests, Kaplan–Meier survival, and Cox regression analyses.ResultsThe most common histopathologies of vulvar sarcomas were dermatofibrosarcomas (85/315, 27%) and leiomyosarcomas (72/315, 22.9%). Rhabdomyosarcomas (18/315, 5.7%), liposarcomas (16/315, 5.1%), and malignant fibrous histiocytomas (16/315, 5.1%) were less frequent. The majority of patients underwent surgery (292/315, 92.7%), which included lymph node dissections in 21.6% (63/292). Survival and lymph node involvement varied significantly with histologic subtype. The 5-year disease-specific survival for dermatofibrosarcomas, liposarcomas, and fibrosarcomas was 100% and only 60.3% and 62.5% for malignant fibrous histiocytomas and rhabdomyosarcomas, respectively. None of the patients with (dermato)fibrosarcomas, liposarcomas, or leiomyosarcomas had positive lymph nodes, in contrast to rhabdomyosarcomas and malignant fibrous histiocytomas with 77.8% and 40% positive lymph nodes, respectively. The 5-year disease-specific survival for women with positive lymph nodes was 0%.ConclusionsVulvar sarcomas are heterogeneous with survival highly dependent on the histopathologic subtype. While surgical excision is the mainstay of treatment for all vulvar sarcomas, staging lymphadenectomy should be deferred for (dermato)fibrosarcomas, liposarcomas, and leiomyosarcomas as there were no cases of lymph nodes metastases.


1978 ◽  
Vol 87 (5_suppl) ◽  
pp. 2-4 ◽  
Author(s):  
Seymour R. Cohen ◽  
Benjamin H. Landing ◽  
Hart Isaacs

Intratracheal tumors are rare in children. A case is reported of a two-year-old female child with a fibrous histiocytoma of the trachea which caused severe respiratory obstruction and persistent right middle lobe pneumonia. Fibrous histiocytomas are basically benign tumors of histiocytes and have been mistaken for other tumors such as fibroma, sclerosing hemangioma, neurilemoma, fibromatosis, hemangiopericytoma, fibrosarcoma, and some primitive sarcomas. Fibrous histiocytomas have not been reported in the trachea or bronchi. The patient was treated with endoscopic removal of the tumor, and has remained free of disease to this date.


1984 ◽  
Vol 19 (1) ◽  
pp. 81-83 ◽  
Author(s):  
Tom Tracy ◽  
James P. Neifeld ◽  
Richard M. DeMay ◽  
Arnold M. Salzberg

Cancer ◽  
2006 ◽  
Vol 106 (12) ◽  
pp. 2725-2733 ◽  
Author(s):  
Elizabeth Fabre-Guillevin ◽  
Jean-Michel Coindre ◽  
Nicolas de Saint Aubain Somerhausen ◽  
Francoise Bonichon ◽  
Eberhard Stoeckle ◽  
...  

2017 ◽  
Vol 22 (01) ◽  
pp. 094-102 ◽  
Author(s):  
Austin Nguyen ◽  
Adam Vaudreuil ◽  
Paul Haun ◽  
Gabriel Caponetti ◽  
Christopher Huerter

Introduction Benign fibrous histiocytomas are common lesions of the skin that rarely affect the tongue. Such cases are available in the literature exclusively as case reports. Similarly, malignant fibrous histiocytoma, now classified as undifferentiated pleomorphic sarcoma, is exceedingly rare in the tongue and not fully understood. Objectives This study systematically reviews the available literature discussing the clinical and pathological features of malignant and benign fibrous histiocytomas. Data Synthesis A total of 20 cases were included in this review. Patient-level data were extracted from cases to include clinical presentation, workup, treatment, and outcome. Conclusion Benign fibrous histiocytomas are consistent in clinical and histopathologic presentation. Surgical treatment provides excellent outcome, with no recurrence in all excised cases. Malignant tumors have a more aggressive clinical and pathological presentation. Surgical treatment with possible adjuvant radiotherapy resulted in recurrence in 40% of cases (follow-up of 24 months), and death due to disease in 47% of patients (follow-up of 19 months).


Sign in / Sign up

Export Citation Format

Share Document